Carter et al. found an association between genetic variants in the HMGCR gene region, a proxy for statins, and reduced overall cancer risk, but no associations with other statin‐related gene targets such as PCSK9, LDLR and NPC1L1.8 This evidence concerns the gene PCSK9 and cancer.